10x Genomics (TXG) Free Cash Flow Growth (1y) (2019 - 2026)
10x Genomics (TXG) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 29.17% |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 20.76% |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 67.61% |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 773.10% |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -19.89% |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | -969.23% |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 8.40% |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 12.24% |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | -103.85% |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | 102.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.89% |
| Dec 31, 2025 | 2,116.54% |
| Sep 30, 2025 | 144.37% |
| Jun 30, 2025 | 435.07% |
| Mar 31, 2025 | 284.17% |
| Dec 31, 2024 | 107.91% |
| Sep 30, 2024 | 193.99% |
| Jun 30, 2024 | 122.15% |
| Mar 31, 2024 | -102.95% |
| Dec 31, 2023 | 23.33% |
| Sep 30, 2023 | 59.06% |
| Jun 30, 2023 | 63.14% |
| Mar 31, 2023 | 82.26% |
| Dec 31, 2022 | -19.25% |
| Sep 30, 2022 | 50.05% |
| Jun 30, 2022 | -228.18% |
| Mar 31, 2022 | -13.95% |
| Dec 31, 2021 | 85.71% |
| Sep 30, 2021 | -37.12% |
| Jun 30, 2021 | 218.20% |